Tirzide 10 mg (Tirzepatide INN)
Dual GIP & GLP-1 Receptor Agonist for Type 2 Diabetes Management
🔹 Short Description:
Tirzide® 10 mg contains Tirzepatide INN, a novel dual GIP and GLP-1 receptor agonist used for the management of Type 2 Diabetes Mellitus. It improves glycemic control and supports weight reduction under physician supervision.
💊 Pharmacology:
Tirzepatide is a first-in-class dual incretin receptor agonist that activates:
This dual mechanism:
-
Enhances glucose-dependent insulin secretion
-
Reduces glucagon levels
-
Delays gastric emptying
-
Promotes satiety and weight loss
-
Improves overall glycemic control
It provides superior HbA1c reduction compared to traditional GLP-1 therapies in many patients.
📌 Indications:
Tirzide 10 mg is indicated for:
-
Type 2 Diabetes Mellitus as an adjunct to diet and exercise
-
Patients requiring improved glycemic control
-
May also support weight management in diabetic patients
Not indicated for Type 1 Diabetes or diabetic ketoacidosis.
💉 Dosage & Administration:
-
Starting dose: 2.5 mg once weekly (subcutaneous injection)
-
Dose escalation may occur based on physician recommendation
-
Administer on the same day each week
-
Can be taken with or without meals
-
Injection sites: abdomen, thigh, or upper arm
Follow medical guidance strictly for titration.
⚠️ Precautions & Warnings:
-
Monitor blood glucose regularly
-
Risk of gastrointestinal side effects (nausea, vomiting)
-
Caution in patients with history of pancreatitis
-
Monitor for hypoglycemia if used with insulin or sulfonylureas
-
Not recommended in patients with severe gastrointestinal disease
❌ Contraindications:
-
Hypersensitivity to Tirzepatide
-
Personal or family history of medullary thyroid carcinoma (MTC)
-
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
🤰 Pregnancy & Lactation:
-
Not recommended during pregnancy
-
Breastfeeding should be avoided during treatment
-
Effective contraception advised during therapy
⚕️ Side Effects:
Common side effects include:
-
Nausea
-
Vomiting
-
Diarrhea
-
Decreased appetite
-
Abdominal discomfort
-
Injection site reactions
Serious but rare:
🧊 Storage Conditions: